Search results
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
GSK’s Use of AI in Vaccine Tech, Drug Discovery: Tech Disruptors - Bloomberg
Bloomberg· 6 days agoUnderstand every aspect of the global economy – and know how to make your next move.
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 4 days agoThe shot was also 68.4% effective against acute respiratory disease. William Blair analyst Myles...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 1 day agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
seattlepi.com· 5 days agoMore than 10 million older adults have gotten either Pfizer or GSK single-dose shots since early...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 4 days ago, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving...
Analyst Report: GSK plc
Morningstar Research via Yahoo Finance· 1 day agoIn the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory ...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 5 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 4 days ago/Seretide sales were down 13%, while sales of Revlar/Breo Ellipta were up 4%. In General Medicines, ...
